COLAVSGTBP• 12 Months (Normalized)
COLA vs GTBP (Columbus Acquisition Corp vs GT Biopharma Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
COLA Performance $7.3
-28.64%
Columbus Acquisition Corp
Normalized Baseline0.00%
GTBP Performance $6.88
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-28.64 pts
GTBP outperforming by 28.64 percentage points
COLAGTBP
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
COLA GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(250 dates)
| Date | COLA Price | COLA Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 30, 2026 | $7.30 | -28.64% | $- | - | |
| Sep 29, 2026 | $10.45 | +2.15% | $6.88 | +975.90% | -973.75% |
| Sep 28, 2026 | $10.64 | +3.99% | $6.80 | +964.16% | -960.17% |
| Sep 25, 2026 | $10.45 | +2.15% | $6.89 | +978.25% | -976.10% |
| Sep 24, 2026 | $10.70 | +4.59% | $6.83 | +968.86% | -964.27% |
| Sep 23, 2026 | $10.70 | +4.59% | $7.10 | +1011.11% | -1006.52% |
| Sep 22, 2026 | $10.74 | +4.99% | $- | - | |
| Sep 21, 2026 | $11.25 | +9.97% | $7.18 | +1023.63% | -1013.66% |
| Sep 18, 2026 | $10.70 | +4.59% | $7.16 | +1020.50% | -1015.91% |
| Sep 17, 2026 | $10.65 | +4.11% | $7.49 | +1072.14% | -1068.03% |
| Sep 16, 2026 | $10.83 | +5.87% | $7.81 | +1122.22% | -1116.35% |
| Sep 15, 2026 | $10.66 | +4.20% | $9.00 | +1308.45% | -1304.25% |
| Sep 14, 2026 | $10.76 | +5.18% | $11.63 | +1720.03% | -1714.85% |
| Sep 11, 2026 | $10.61 | +3.71% | $8.61 | +1247.42% | -1243.71% |
| Sep 10, 2026 | $8.30 | -18.87% | $6.18 | +867.14% | -886.01% |
Page 1 of 17